Member Info for ontarget

Looks like they are delaying my 1m buy by 2 hours..

Or simply people recognising that at £7m this is very good value.

Juno, Callum's dream is still there and funding is in place to have another go.

Gorgeous Gorge which looks very exciting and relatively low risk.

PEL-94 which could surprise with a farm-out at any time.

Yep managed to add 1m at just under 1.4p earlier. Should show up at 11:46.

Bid/offer was 1.35-1.5 at that timestamp on 2/1, so you'd have to assume the 5m is a buy at 1.45. Then a 2.1m sell later the same day and a 1m buy from today.

I think the new MRE will be towards the end of Q1, as indicated by the company. We still have assay results on 6 out of the 9 holes recently drilled to come yet!

What "additional appraisal"? There is no line that talks about this. The RNS said " further progressing" the appraisal - read it again or go to specsavers.

Live, it's on investormeetcompany

Are you purposely being thick?

I read the RNS and it said

"As we enter the holiday season, the Company will be hosting a webinar on 23 December 2025 at 17:00 GMT to share results up until that time and to discuss next steps in further progressing appraisal efforts on the Ahpun field."

Have we had an RNS sharing results up until that time and next steps?

No we haven't, so there will be one on Monday.

Sounds like you were one of the twitter trolls too?

If it hadn't been for trolls like BSR they probably wouldn't have needed to restrict it.

In common with a lot of companies on twitter. You can also still reply if you are 'verified'.

GMET market cap is just under $250M

"When good drill results are issued now the hardly seem to give an uplift."

Perhaps due to ex-directors selling into them?

Don't think so, it was at almost the high of the day. Most volume has been below that.

Callum for CEO!

Https://x.com/geo_critical/status/2000828305621373129?s=12&t=DyLGaIWiuD14-OzEHiroFQ

Regarding this idea of 'fast tracking' assays, imagine in this world of high gold prices where exploration activity is at fever pitch, that there was a way for a company to jump the long queue so they would get their assay results much quicker, for a cheap price.

How many companies would take up this 'fast track' option?

Virtually all of them would, and so there would be no fast track anymore, just a more expensive long queue.

The logical conclusion is therefore that if there is a fast track option it must be prohibitively expensive.

Surprised by the price but glad they have got this out of the way now.

Mates rates before positive Juno assay results?

Presumably you don't either Supra3, given you were buying at higher prices only last week?